Considering CC’s ability to enhance LH levels and the observed low LH levels in patients with obesity, we hypothesize that clomiphene citrate compensates for diminished hypothalamic-pituitary function in obese women, and leading to reduced premature LH surge. Here, PLOD1 is linked to obesity due to melanocortin 4 receptor deficiency.